October 4, 2019 (University of Miami press release)

An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since its founding in 2014. Now the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium is aiming for new breakthroughs after receiving a five-year, $7.9 million renewal grant from the National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

Click here to read the full article